June 7, 2016 – The Advertising Coalition (TAC) Executive Director Jim Davidson gave industry’s next generation a comprehensive overview of the battle the prescription drug industry has fought over the years to protect its right to advertise at the recent Coalition for Healthcare Communication Rising Leaders Conference held in May in Washington, D.C. Davidson summarized […]
Read moreTag: DTC advertising
DTC advertisingThe Advertising Coalition Reminds FDA of First Amendment Limits to Advertising Regulation
May 9, 2016 – In an April 29 comment to the FDA on its recent proposal to conduct research on how animation in direct-to-consumer (DTC) prescription drug advertising affects viewer comprehension, The Advertising Coalition (TAC) asks the agency to consider the Office of Prescription Drug Promotion’s mission statement “in the context of a series of […]
Read moreNYTimes: Ban on Drug Ads Would Also Eliminate Ad Benefits
March 14, 2016 — The American Medical Association (AMA) as well as Rep. Rosa DeLauro (D-Conn.) and Sen. Al Franken (D-Minn.) are calling for a ban on or restrictions to direct-to-consumer (DTC) drug ads that might result in a dip in drug sales, but also would hurt patients by eliminating the advantages of DTC drug […]
Read moreSen. Franken Introduces Legislation to End Drug Advertising Tax Breaks
March 4, 2016 – Yesterday Sen. Al Franken (D-Minn.) introduced legislation that would end the tax deduction that drug companies now take for their marketing costs, a move that seemingly puts industry on notice that Franken wants to be a leader on this issue in the Senate, where it last was raised in 2007. “We […]
Read moreDeLauro's House Bill to Restrict DTC Advertising Likely Would Violate First Amendment
Feb. 18, 2016 – A bill introduced in the House last week by Rep. Rosa DeLauro (D-Conn.) — the Responsibility in Drug Advertising Act of 2016 (H.R. 4565) – would prohibit direct-to-consumer (DTC) advertising for the first three years following a drug’s approval and allow the Department of Health and Human Services (HHS) to waive […]
Read moreIndustry Prepares for DTC Battle
Jan. 12, 2016 – As criticism of prescription drug direct-to-consumer (DTC) advertising continues to be levied by presidential hopefuls and others who blame DTC ads for both higher drug prices and a greater demand for drugs, industry organizations are preparing for what may be a long battle. Although it is unlikely that any action will […]
Read moreAre DTC Ads Being Mischaracterized?
Dec. 28, 2015 – The supposed ill effects of direct-to-consumer (DTC) advertising are being levied without much evidence, according to a recent article by Robert Palmer, EVP, director of Digital and Video for JUICE Pharma Worldwide. The well-balanced article, “The DTC Advertising Dilemma,” posted on the JUICE blog Dec. 14, discusses the recent American Medical […]
Read moreSave the Date: PhRMA’s Lori Reilly to Speak to Coalition on Feb. 16
Dec. 14, 2015 – Lori Reilly, executive vice president, Policy and Research, at the Pharmaceutical Research and Manufacturers of America (PhRMA), will speak to Coalition for Healthcare Communication members in New York City at 9 a.m. on Tuesday, Feb. 16, and will share her thoughts on “Managing Pricing and Marketing Challenges in 2016.” “Come hear […]
Read moreCoalition Arms Industry with Tool Kit to Defend DTC Advertising
Dec. 14, 2015 – With medical marketing being targeted by politicians and the media as one cause of high drug prices, the Coalition for Healthcare Communication is helping its members take action against this claim by providing them with a direct-to-consumer (DTC) Tool Kit that includes talking points and other informational resources. “The public and […]
Read moreNBER: DTC Ads Increase Treatment of the Undertreated and Undiagnosed, Improve Drug Adherence
Dec. 7, 2015 – While direct-to-consumer (DTC) advertising increases the number of drug prescriptions, it also boosts the number of people being treated for commonly undertreated conditions and improves drug adherence, according to a new study released by the National Bureau of Economic Research (NBER). The NBER study, “Prescription Drug Advertising and Drug Utilization: The […]
Read more